We use cookies on our website. Carry on browsing if you’re happy with this or find out more

News

:

Kymab VP Paul Kellam evidence to House of Lords

Paul Kellam

Professor Paul Kellam, Kymab’s Vice-President of Infectious Disease and Vaccines, provided evidence at the House of Lords Science and Technology Committee’s inquiry on Life Sciences and the Industrial Strategy.

The evidence session, at 10.00 am on Tuesday 16 January, 2018, is available to view or to download as audio from www.parliamentlive.tv.

Professor Kellam represented the Microbiology Society before the Committee. Topics planned for review included: the January 2017 Green Paper ‘Building our industrial strategy’; the definition of life sciences in this context; the influence of Brexit in the life science sector.

Find out which events we'll be attending this year

View events